NasdaqGM - Nasdaq Real Time Price USD

biote Corp. (BTMD)

Compare

5.67

+0.13

+(2.35%)

At close: January 14 at 4:00:01 PM EST

5.80

+0.13

+(2.29%)

Pre-Market: 5:58:01 AM EST

Is biote Corp. (BTMD) Stock Outpacing Its Medical Peers This Year?

Here is how biote Corp. (BTMD) and Doximity (DOCS) have performed compared to their sector so far this year.

Zacks 27 days ago

DOCS

BTMD
+2.35%
Should Value Investors Buy biote Corp. (BTMD) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks 29 days ago

OSUR

BTMD
+2.35%
Does biote Corp. (BTMD) Have the Potential to Rally 43.89% as Wall Street Analysts Expect?

The mean of analysts' price targets for biote Corp. (BTMD) points to a 43.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Zacks last month

BTMD
+2.35%
Are Investors Undervaluing biote Corp. (BTMD) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks last month

BTMD
+2.35%
biote Corp. (BTMD) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

After losing some value lately, a hammer chart pattern has been formed for biote Corp. (BTMD), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

Zacks last month

BTMD
+2.35%
Biote Corp (BTMD) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Enhancements

Biote Corp (BTMD) reports double-digit revenue growth and strategic advancements despite temporary disruptions and adjusted guidance.

GuruFocus.com last month

BTMD
+2.35%
Wall Street Analysts Predict a 76.99% Upside in biote Corp. (BTMD): Here's What You Should Know

The average of price targets set by Wall Street analysts indicates a potential upside of 77% in biote Corp. (BTMD). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Zacks last month

BTMD
+2.35%
Is biote Corp. (BTMD) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks 2 months ago

BTMD
+2.35%
Biote Corp. (BTMD) Beats Q3 Earnings Estimates

biote Corp. (BTMD) delivered earnings and revenue surprises of 266.67% and 0%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks 2 months ago

BTMD
+2.35%
Biote Reports Third Quarter 2024 Financial Results

IRVING, Texas, November 12, 2024--Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced financial results for the third quarter ended September 30, 2024.

Business Wire 2 months ago

BTMD
+2.35%
Wall Street Analysts See an 88.04% Upside in biote Corp. (BTMD): Can the Stock Really Move This High?

The consensus price target hints at an 88% upside potential for biote Corp. (BTMD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Zacks 2 months ago

BTMD
+2.35%
Biote Schedules Third Quarter 2024 Financial Results Release and Conference Call

IRVING, Texas, October 29, 2024--biote Corp. (Nasdaq: BTMD) ("Biote" or the "Company"), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced the Company will provide third quarter financial results on Tuesday, November 12, 2024, after the close of the market. A conference call to discuss the firm’s results will be held at 5:00 p.m. ET. the same day.

Business Wire 2 months ago

BTMD
+2.35%
Is biote Corp. (BTMD) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks 2 months ago

PAHC

BTMD
+2.35%
Biote Reports Second Quarter 2024 Financial Results

IRVING, Texas, August 08, 2024--Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced financial results for the second quarter ended June 30, 2024.

Business Wire 5 months ago

BTMD
+2.35%
Biote Schedules Second Quarter 2024 Financial Results Release and Conference Call

IRVING, Texas, July 25, 2024--biote Corp. (Nasdaq: BTMD) ("Biote" or the "Company"), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced the Company will provide second quarter financial results on Thursday, August 8, 2024, after the close of the market. A conference call to discuss the firm’s results will be held at 5:00 p.m. ET. the same day.

Business Wire 5 months ago

BTMD
+2.35%
Zacks.com featured highlights include ADMA Biologics, American Superconductor, biote, Lincoln Educational Services and Corcept Therapeutics

ADMA Biologics, American Superconductor, biote, Lincoln Educational Services and Corcept Therapeutics have been highlighted in this Screen of The Week article.

Zacks 5 months ago

CORT

ADMA

BTMD
+2.35%
5 Stocks With Recent Price Strength to Tap Wall Street Rally

Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are ADMA, AMSC, BTMD, LINC, CORT.

Zacks 5 months ago

BTMD
+2.35%
Wall Street Analysts Think biote Corp. (BTMD) Could Surge 25.44%: Read This Before Placing a Bet

The average of price targets set by Wall Street analysts indicates a potential upside of 25.4% in biote Corp. (BTMD). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Zacks 6 months ago

BTMD
+2.35%
biote Corp. (BTMD) Surges 10.4%: Is This an Indication of Further Gains?

biote Corp. (BTMD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Zacks 6 months ago

BTMD
+2.35%
OMI
Biote Announces $60 Million Agreement to Repurchase 8.3 Million Shares and Cancel Approximately 4.0 Million Earnout Shares

IRVING, Texas, June 20, 2024--biote Corp. (NASDAQ: BTMD) ("Biote" or the "Company"), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced it has signed a binding term sheet with Marci M. Donovitz, stockholder of Biote, to resolve litigation ("Donovitz Litigation"). For $60 million in the aggregate, Biote will repurchase all of the approximately 8.3 million of the Paired Interests and/or Class A

Business Wire 6 months ago

BTMD
+2.35%

Performance Overview

Return	BTMD	S&P 500
YTD	-4.06%	-1.08%
1-Year	+25.17%	+22.14%
3-Year	-42.38%	+25.41%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

biote Corp. (BTMD)

Is biote Corp. (BTMD) Stock Outpacing Its Medical Peers This Year?

Should Value Investors Buy biote Corp. (BTMD) Stock?

Does biote Corp. (BTMD) Have the Potential to Rally 43.89% as Wall Street Analysts Expect?

Are Investors Undervaluing biote Corp. (BTMD) Right Now?

biote Corp. (BTMD) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

Biote Corp (BTMD) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Enhancements

Wall Street Analysts Predict a 76.99% Upside in biote Corp. (BTMD): Here's What You Should Know

Is biote Corp. (BTMD) Stock Undervalued Right Now?

Biote Corp. (BTMD) Beats Q3 Earnings Estimates

Biote Reports Third Quarter 2024 Financial Results

Wall Street Analysts See an 88.04% Upside in biote Corp. (BTMD): Can the Stock Really Move This High?

Biote Schedules Third Quarter 2024 Financial Results Release and Conference Call

Is biote Corp. (BTMD) a Great Value Stock Right Now?

Biote Reports Second Quarter 2024 Financial Results

Biote Schedules Second Quarter 2024 Financial Results Release and Conference Call

Zacks.com featured highlights include ADMA Biologics, American Superconductor, biote, Lincoln Educational Services and Corcept Therapeutics

5 Stocks With Recent Price Strength to Tap Wall Street Rally

Wall Street Analysts Think biote Corp. (BTMD) Could Surge 25.44%: Read This Before Placing a Bet

biote Corp. (BTMD) Surges 10.4%: Is This an Indication of Further Gains?

Biote Announces $60 Million Agreement to Repurchase 8.3 Million Shares and Cancel Approximately 4.0 Million Earnout Shares

Performance Overview